Malaria Drug May Help In Cancer Fight, Cancer Research UK Radiation Research Centre Study

Published: Jul 25, 2016

An off-patent malaria drug could help to destroy cancer cells by making them more susceptible to radiotherapy, according to early work that has prompted British scientists to start a clinical trial.

Researchers reported on Monday that atovaquone boosted oxygen levels in tumor cells in mice, making radiotherapy more effective against a range of cancer types, including lung, bowel, brain and head and neck cancer.

Cancer cells with low oxygen levels are more difficult to treat with radiotherapy and are more likely to spread to other parts of the body.

Back to news